Details for New Drug Application (NDA): 009048
✉ Email this page to a colleague
NDA 009048 describes OXSORALEN, which is a drug marketed by Valeant Pharm Intl and Bausch and is included in two NDAs. Additional details are available on the OXSORALEN profile page.
The generic ingredient in OXSORALEN is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
The generic ingredient in OXSORALEN is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
Summary for 009048
| Tradename: | OXSORALEN |
| Applicant: | Valeant Pharm Intl |
| Ingredient: | methoxsalen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009048
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
